Drawing for MED·PACTO

USPTO serial 79337177

MED·PACTO

Reviewed by CopyMark Law Group

Reg. 7102440Status 700Registered
Filing date
Status date
Registration date
Jul 11, 2023
Examiner
BARRETT, LEAH N
Law office
TMEG LAW OFFICE 106

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MED·PACTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP405 Lexington AvenueNew York, NY 10174UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceuticals, namely, pharmaceutical products for the treatment of cancer; medicines for human purposes for treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of cancer; diagnostic preparations for medical purposes; medical diagnostic reagents; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of gastrointestinal diseases; pharmaceutical preparations for the treatment of bone disorders; pharmaceutical preparations for the treatment of liver diseases; vaccines; dietary supplements; nutraceuticals for the treatment of cancerACTIVE—
010Medical apparatus and instruments for treatment of cancer; medical diagnostic apparatus for testing cancer cells; electromagnetic, ultrasonic and nuclear medicine diagnostic imaging apparatus for medical use; apparatus for clinical diagnosis, namely, electromagnetic, ultrasonic and nuclear medicine diagnostic apparatus, x-ray diagnostic apparatus, medical diagnostic apparatus for the detection of cancer; surgical apparatus and instruments for medical use; medical testing apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the field of cancer, of cancer cells, and other tissue-based diagnostic testing, cytology and cell-based testing; surgical apparatus and instruments for medical or veterinary use; furniture especially made for medical purposes; cases fitted for medical instrumentsACTIVE—
035Retail store services featuring pharmaceuticals; wholesale store services featuring pharmaceuticals; retail store services featuring anti-cancer preparations; wholesale store services featuring anti-cancer preparations; retail store services featuring medical apparatus and instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring cosmetics; wholesale store services featuring cosmetics; import-export agency services; promoting the goods and services of others by means of operating an on-line comprehensive shopping mall with links to the retail web sites of othersACTIVE—
042Pharmaceutical drug development; drug discovery services; laboratory research in the field of pharmaceuticals; consultancy relating to pharmaceutical research and development; pharmaceutical research and development; pharmaceutical drug development services; pharmaceutical product evaluation; product development of diagnostic apparatus; product design of diagnostic apparatus; testing, inspection and research services of pharmaceuticals, cosmetics and foodstuffs; basic and clinical research in the field of medicine and vaccine developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 6, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 12, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 12, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 11, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 11, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 11, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 25, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 25, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 25, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 5, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Apr 5, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 21, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 21, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Mar 21, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 21, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 10, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 9, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 9, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 7, 2023RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2023RFRRREFUSAL PROCESSED BY MPU—
Nov 1, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 31, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 21, 2022DOCKASSIGNED TO EXAMINER—
Apr 5, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 1, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 31, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance